Literature DB >> 20144691

Specific inhibitory effect of amyloid-beta on presynaptic muscarinic receptor subtypes modulating neurotransmitter release in the rat nucleus accumbens.

M Grilli1, F Lagomarsino, S Zappettini, S Preda, E Mura, S Govoni, M Marchi.   

Abstract

In this study we investigate on the effect of amyloid-beta1-40 (A beta 1-40) on the oxotremorine (OXO)-induced release of [(3)H] dopamine (DA), [(3)H]GABA and [(3)H]acetylcholine (ACh) from synaptosomes in the rat nucleus accumbens (NAc). OXO in presence of himbacine (HIMBA) was able to increase the basal release of [(3)H]GABA. The OXO-elicited [(3)H]GABA overflow was significantly antagonized by atropine (A; 94%), by the M3 antagonists DAU5884 (96%) and 4-DAMP (70%), and by A beta 1-40 (65%). Exposure of NAc synaptosomes to OXO produced a dose-dependent increase of [(3)H]DA overflow which was antagonized by A, partially inhibited by A beta 1-40 (100 nM) but unaffected by DAU5884 and 4-DAMP. The K(+)-evoked [(3)H]ACh overflow was inhibited by OXO. This effect was counteracted by the M2 antagonist AFDX-116 but not by the selective M4 antagonist mamba toxin 3 (MT3). The K(+)-evoked [(3)H]GABA overflow was also inhibited by OXO but conversely, this effect was counteracted by MT3 and not by AFDX-116. A beta 1-40 (100 nM) did not modify the inhibitory effect of OXO both on the K(+)-evoked [(3)H]ACh and [(3)H]GABA overflow. The results show that in the rat NAc, A beta 1-40 selectively inhibits the function of the muscarinic subtypes which stimulate neurotransmitter release and not those which modulate negatively the stimulated release. (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20144691     DOI: 10.1016/j.neuroscience.2010.01.058

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

Review 1.  CSF and clinical hallmarks of subcortical dementias: focus on DLB and PDD.

Authors:  Alessandro Stefani; Livia Brusa; Enrica Olivola; Mariangela Pierantozzi; Alessandro Martorana
Journal:  J Neural Transm (Vienna)       Date:  2012-05-24       Impact factor: 3.575

2.  Different pharmacology of N-desmethylclozapine at human and rat M2 and M 4 mAChRs in neocortex.

Authors:  S Gigout; S Wierschke; C Dehnicke; R A Deisz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-01-16       Impact factor: 3.000

Review 3.  SUMO and Alzheimer's disease.

Authors:  Linda Lee; Mikako Sakurai; Shinsuke Matsuzaki; Ottavio Arancio; Paul Fraser
Journal:  Neuromolecular Med       Date:  2013-08-25       Impact factor: 3.843

4.  Dual effect of beta-amyloid on α7 and α4β2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus.

Authors:  Elisa Mura; Stefania Zappettini; Stefania Preda; Fabrizio Biundo; Cristina Lanni; Massimo Grilli; Anna Cavallero; Guendalina Olivero; Alessia Salamone; Stefano Govoni; Mario Marchi
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

Review 5.  (Dys)regulation of Synaptic Activity and Neurotransmitter Release by β-Amyloid: A Look Beyond Alzheimer's Disease Pathogenesis.

Authors:  Francesca Fagiani; Cristina Lanni; Marco Racchi; Stefano Govoni
Journal:  Front Mol Neurosci       Date:  2021-02-24       Impact factor: 5.639

6.  Amyloid Beta-Mediated Changes in Synaptic Function and Spine Number of Neocortical Neurons Depend on NMDA Receptors.

Authors:  Michaela K Back; Sonia Ruggieri; Eric Jacobi; Jakob von Engelhardt
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

7.  Effects of soluble β-amyloid on the release of neurotransmitters from rat brain synaptosomes.

Authors:  Guendalina Olivero; Massimo Grilli; Jiayang Chen; Stefania Preda; Elisa Mura; Stefano Govoni; Mario Marchi
Journal:  Front Aging Neurosci       Date:  2014-07-15       Impact factor: 5.750

8.  Soluble beta amyloid evokes alteration in brain norepinephrine levels: role of nitric oxide and interleukin-1.

Authors:  Maria G Morgese; Marilena Colaianna; Emanuela Mhillaj; Margherita Zotti; Stefania Schiavone; Palma D'Antonio; Andrew Harkin; Valentina Gigliucci; Patrizia Campolongo; Viviana Trezza; Angelo De Stradis; Paolo Tucci; Vincenzo Cuomo; Luigia Trabace
Journal:  Front Neurosci       Date:  2015-11-05       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.